Global racial, ethnic, and gender diversity among participants enrolled in the PURPOSE-2 trial of lenacapavir for pre-exposure prophylaxis (PrEP)

Authors

• J. Gallardo-Cartagena, Universidad Nacional Mayor de San Marcos, Lima, Peru
• N. Phanuphak, Institute of HIV Research and Innovation, Bangkok, Thailand
• N. Ndlovu, University of the Witwatersrand, Johannesburg, South Africa
• M.H. Losso, Hospital General De Agudos J M Ramos Mejía, Buenos Aires, Argentina
• M. Clement, LSU Health Sciences Center - New OrleansFollow
• V.D.C. Lucio, Emory University School of Medicine, Atlanta, GA
• B. Grinsztejn, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil
• K.H. Mayer, Harvard University Medical School, Boston, MA
• Y. Zhao, Gilead Sciences, Inc., Foster City, CA
• L. Brown, Gilead Sciences, Inc., Foster City, CA
• C. Carter, Gilead Sciences, Inc., Foster City, CA
• M. Das, Gilead Sciences, Inc., Foster City, CA
• O. Ogbuagu, Yale School of Medicine, New Haven, CT

Document Type

Conference Proceeding

Publication Date

10-1-2024

Publication Title

Journal of the International AIDS Society

Abstract

5th HIV Research for Prevention Conference, HIVR4P 2024, October 6 -10, 2024, Peru, Lima

First Page

69

Volume

27

Issue

5, Supplement

Comments

Abstract Number: OA0102

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Recommended Citation

Gallardo-Cartagena, J.; Phanuphak, N.; Ndlovu, N.; Losso, M.H.; Clement, M.; Lucio, V.D.C.; Grinsztejn, B.; Mayer, K.H.; Zhao, Y.; Brown, L.; Carter, C.; Das, M.; and Ogbuagu, O., "Global racial, ethnic, and gender diversity among participants enrolled in the PURPOSE-2 trial of lenacapavir for pre-exposure prophylaxis (PrEP)" (2024). School of Medicine Faculty Publications. 4546.
https://digitalscholar.lsuhsc.edu/som_facpubs/4546
10.1002/jia2.26351